Biogen Idec Inc. (NASDAQ:BIIB) today announced it will report second
quarter 2009 financial results on Thursday, July 16, 2009, before the
financial markets open.
Following the release of the financials, the Company will host a live
webcast where Biogen Idec management will discuss the financial results,
at 8:30 am ET. To access the live webcast, please go to Biogen Idec’s
website at investor.biogenidec.com. Following the live webcast, an
archived version of the call will be available at the same URL, for one
month.
About Biogen Idec
Biogen Idec creates new standards of care in therapeutic areas with high
unmet medical needs. Founded in 1978, Biogen Idec is a global leader in
the discovery, development, manufacturing, and commercialization of
innovative therapies. Patients in more than 90 countries benefit from
Biogen Idec's significant products that address diseases such as
lymphoma, multiple sclerosis, and rheumatoid arthritis. For product
labeling, press releases and additional information about the company,
please visit www.biogenidec.com.
Biogen Idec
Rob Jacobson, 877-420-2442
